Eli Zavialov, PhD, is Scientific Director, Regulatory CMC Dossier Development and Operations, at Johnson & Johnson. Eli joined J&J in 2011, where he made significant contributions to the preparation and delivery of technical CMC sections to support global clinical trial and marketing applications across a diverse portfolio of biologics and small molecules. In his current role, Eli serves as a single point of contact for GRA CMC senior leadership on strategic dossier needs and requirements. Eli works in close partnership with GRA CMC and matrix functions to ensure that dossier submission projects are aligned with key stakeholder requirements. Eli previously worked in chemical development and technical operations at Merck and Schering-Plough in various positions of increasing responsibility. Eli holds a PhD in organic and bioorganic chemistry from the University of Southern California, and BSc in chemistry from Moscow State University, Moscow, Russia. He joined ISPE in 2019.